136 related articles for article (PubMed ID: 21067829)
1. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study.
Adunsky A; Chandler J; Heyden N; Lutkiewicz J; Scott BB; Berd Y; Liu N; Papanicolaou DA
Arch Gerontol Geriatr; 2011; 53(2):183-9. PubMed ID: 21067829
[TBL] [Abstract][Full Text] [Related]
2. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
Bach MA; Rockwood K; Zetterberg C; Thamsborg G; Hébert R; Devogelaer JP; Christiansen JS; Rizzoli R; Ochsner JL; Beisaw N; Gluck O; Yu L; Schwab T; Farrington J; Taylor AM; Ng J; Fuh V;
J Am Geriatr Soc; 2004 Apr; 52(4):516-23. PubMed ID: 15066065
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
4. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture.
Huusko TM; Karppi P; Kautiainen H; Suominen H; Avikainen V; Sulkava R
Calcif Tissue Int; 2002 Dec; 71(6):478-84. PubMed ID: 12370798
[TBL] [Abstract][Full Text] [Related]
8. No rest for the wounded: early ambulation after hip surgery accelerates recovery.
Oldmeadow LB; Edwards ER; Kimmel LA; Kipen E; Robertson VJ; Bailey MJ
ANZ J Surg; 2006 Jul; 76(7):607-11. PubMed ID: 16813627
[TBL] [Abstract][Full Text] [Related]
9. A specific inpatient aquatic physiotherapy program improves strength after total hip or knee replacement surgery: a randomized controlled trial.
Rahmann AE; Brauer SG; Nitz JC
Arch Phys Med Rehabil; 2009 May; 90(5):745-55. PubMed ID: 19406293
[TBL] [Abstract][Full Text] [Related]
10. Muscle function and functional outcome following standard antegrade reamed intramedullary nailing of isolated femoral shaft fractures.
Helmy N; Jando VT; Lu T; Chan H; O'Brien PJ
J Orthop Trauma; 2008 Jan; 22(1):10-5. PubMed ID: 18176159
[TBL] [Abstract][Full Text] [Related]
11. Effects of resistance training on lower-extremity impairments in older people with hip fracture.
Portegijs E; Kallinen M; Rantanen T; Heinonen A; Sihvonen S; Alen M; Kiviranta I; Sipilä S
Arch Phys Med Rehabil; 2008 Sep; 89(9):1667-74. PubMed ID: 18760151
[TBL] [Abstract][Full Text] [Related]
12. Performance-based or self-report measures of physical function: which should be used in clinical trials of hip fracture patients?
Latham NK; Mehta V; Nguyen AM; Jette AM; Olarsch S; Papanicolaou D; Chandler J
Arch Phys Med Rehabil; 2008 Nov; 89(11):2146-55. PubMed ID: 18996244
[TBL] [Abstract][Full Text] [Related]
13. Pattern of functional change during rehabilitation of patients with hip fracture.
Latham NK; Jette DU; Warren RL; Wirtalla C
Arch Phys Med Rehabil; 2006 Jan; 87(1):111-6. PubMed ID: 16401448
[TBL] [Abstract][Full Text] [Related]
14. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
15. Can elderly patients who have had a hip fracture perform moderate- to high-intensity exercise at home?
Mangione KK; Craik RL; Tomlinson SS; Palombaro KM
Phys Ther; 2005 Aug; 85(8):727-39. PubMed ID: 16048421
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
[TBL] [Abstract][Full Text] [Related]
17. An analysis of gait changes and functional outcome in patients surgically treated for displaced acetabular fractures.
Engsberg JR; Steger-May K; Anglen JO; Borrelli J
J Orthop Trauma; 2009; 23(5):346-53. PubMed ID: 19390362
[TBL] [Abstract][Full Text] [Related]
18. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
